Navigation Links
Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 Supplements

JERUSALEM, DEXTER, Michigan, February 11, 2013 /PRNewswire/ --

Qualitas Health and Valicor Renewables announced today a strategic partnership that will accelerate the launch of high-EPA Omega-3 oil from algae. The companies have joined forces to combine their expertise and experience in biology, advanced chemistry and technology commercialization to make a significant impact on the global Omega-3 market with next-generation algae based products.



"We are excited to work with Valicor Renewables as our strategic extraction partner" says Dr. Isaac Berzin , CTO of Qualitas Health. "Exclusive access to Valicor's extraction technology gives us a significant technological advantage and reduces the time-to-market of our pure-EPA omega-3 oil from algae. Valicor's technology is proven and practical. It completes the necessary portfolio of technologies needed to manufacture an algae-based Omega-3 supplement on a commercial scale."

"The collaboration between Qualitas and Valicor brings together best-in-class cultivation and strain technology with best-in-class class extraction technology, protected by robust patents" says Dr. Brian Goodall , VP. Business Development at Valicor Renewables. "Valicor's extraction technology is designed to keep the natural algae polar lipids intact while avoiding the use of potentially harmful solvents".

About Qualitas Health:

Qualitas Health is a privately-held company developing high-value vegetarian food supplements and pharmaceutical ingredients based on microalgae. Building on over 10 years' experience in algae cultivation and extraction from the biofuel sector, the company's team has developed a unique and proprietary technology for strain selection, sustainable algae farming, harvesting and oil processing. The technology allows for the effective production of proprietary premium Omega-3 algae oil for a wide range of applications.

About Valicor Renewables   (formerly SRS Energy):

Headquartered in Dexter, Michigan, Valicor services clients throughout the United States in the automotive, aerospace, alternative fuels, algae-derived products, power generation, and steel industries. The company operates three business groups, Environmental Services, Separation Technologies and Renewables, concentrating on the advancement of its technologies in processes and fluid management to meet client needs.  Since beginning the Algae Extraction Program in 2007, Valicor Renewables has established transformative new techniques for the extraction and fractionation of algae oil.  The development of the patent pending Valicor Algafrac™ technologies has provided for commercially scalable processes which efficiently and cost-effectively extract both polar and non-polar lipids.

Yuri Shoshan

SOURCE Qualitas Health Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
2. Trovagene to Present at Leerink Swan Global Healthcare Conference
3. EU Study Finds UK Health Product Benefit Metric Flawed
4. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
5. Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
6. Life Technologies to Present at Leerink Swann Global Healthcare Conference
7. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
8. Nutrex Hawaii Hawaiian Astaxanthin Microalgae May be the Secret to Better Eye Health
9. Providence Health & Services Selects Conflict of Interest Management System
10. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
11. Dr. Alexander Fleming on Searching for Solutions to Metabesity and Healthy Aging
Post Your Comments:
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):